Alicia Bork, Public Information Officer
Wisconsin Controlled Substances Board Schedules Dangerous Drugs
Walker Administration Continues to Fight Drug Abuse
Madison, WI – Today, the Controlled Substances Board voted to take affirmative action on six dangerous drugs. PB-22, SF-PB-22, AB-FUBINACA, ADB-PINACA and U-47700 will be Schedule I drugs while Thiafentanil will be placed as Schedule II. The decision was made at a meeting of the Controlled Substances Board at the Department of Safety and Professional Services (DSPS).
“According to 961.11 (4) of the Controlled Substances Statutes, the Board may take affirmative action to designate a substance as a controlled substance 30 days from the date of publication of the federal final order,” said Doug Englebert, Board Chair. “We are pleased that the U.S. Drug Enforcement Administration (DEA) has decided to schedule these dangerous drugs, allowing us to follow suit and more quickly and efficiently make these drugs illegal in Wisconsin.”
“Today’s motion is another step in the right direction,” said DSPS Secretary Dave Ross. “I am proud of the Board’s work in continuing to combat illicit drugs.”
Thiafentanil, a large-animal anesthetic, will become a Schedule II drug effective October 3. PB-22, SF-PB-22, AB-FUBINACA and ADB-PINACA, all types of Schedule I synthetic marijuana will be effective October 10, and U-47700, a substance with similar effects to heroin, fentanyl and other opioids will also be listed as a Schedule I drug effective November 7, 2016.
“We continue to work to combat drug abuse and misuse, and I applaud the Controlled Substances Board for being proactive and taking affirmative action to fight this growing epidemic,” said Governor Walker.
Housed in the Department of Safety and Professional Services, the Controlled Substances Board has the ability to schedule drugs per § 961.11. Wis. Stats.